Company intelligence / Profile preview

BioInfoComm

Singapore, Singapore
Ownership
Private
Development stage
Other
01

Overview

BioInfoComm (BIC) is a Singapore-based medical technology company specializing in digital health solutions for clinical management and patient care. The company is best known for its Electronic Medical Records (EMR) system, SERRE, and its risk incident reporting software, proMISE IRIS, which are designed to digitize and streamline healthcare workflows. BioInfoComm has established significant partnerships with healthcare providers such as the Kidney Dialysis Foundation (KDF) and Fresenius Medical Care to implement these digital platforms in specialized clinical settings, particularly dialysis centers. Their technology enables automated data recording from medical devices and facilitates seamless data sharing across healthcare institutions to improve medical outcomes for patients with chronic conditions.

Therapeutic areas
EndocrinologyCardiovascularNephrology
Modalities
SoftwareDigital Health
Industry
Biomedical IT and Biomedical Data Platforms
02

Partnerships

Kidney Dialysis FoundationFresenius Medical Care

Beyond the preview

Go deeper on BioInfoComm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioInfoComm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call